The confusion surrounding prostate cancer screening faced by family physicians

Affiliations

Nathan A Hoag et al. Can Urol Assoc J. 2012 Jun.

. 2012 Jun;6(3):194-5.

doi: 10.5489/cuaj.12123.

¹ Department of Urologic Sciences, University of British Columbia, Vancouver, BC.

No abstract available

Comment on

Prostate cancer screening: Attitudes and practices of family physicians in Ontario.
Allard CB, Dason S, Lusis J, Kapoor A. Allard CB, et al. Can Urol Assoc J. 2012 Jun;6(3):188-93. doi: 10.5489/cuaj.11290. Can Urol Assoc J. 2012. PMID: 22664631 Free PMC article.

1. Andriole GL, Grubb RL, Buys SS, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310–9. doi: 10.1056/NEJMoa0810696. - DOI - PMC - PubMed
1. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320–8. doi: 10.1056/NEJMoa0810084. - DOI - PubMed
1. Brett AS, Ablin RJ. Prostate-cancer screening-What the U.S. Preventative Services Task Force left out. N Engl J Med. 2011;365:1949–51. doi: 10.1056/NEJMp1112191. - DOI - PubMed
1. Greene KL, ALbertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update. J Urol. 2009;182:2232–41. doi: 10.1016/j.juro.2009.07.093. - DOI - PubMed
1. Izawa JI, Klotz L, Siemens DR, et al. Prostate cancer screening: Canadian guidelines 2011. Can Urol Assoc J. 2011;5:235–40. doi: 10.5489/cuaj.11134. - DOI - PMC - PubMed